Jenburkt Pharmaceuticals Ltd.
Snapshot View

640.00 -4.25 ▼-0.7%

27 January 2023, 04:01:00 PM
Volume: 2,435

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jenburkt.com
Market Cap 286.79 Cr.
Enterprise Value(EV) 239.54 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 50.20 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 12.75 Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 278.06 Trailing Twelve Months Ending 2022-09
Price to Book Value 2.30 Calculated using Price: 640.00
Dividend Yield 1.88 Period Ending 2022-03
No. of Shares Subscribed 0.45 Cr. 4,481,135 Shares
FaceValue 10
Company Profile
Jenburkt Pharmaceuticals Ltd, a venture to diversify into the healthcare and pharmaceutical industry, was formed in 1985 by the Bhuta family; late Hemendra N. Bhuta was the promoter of the company while the Bhuta Group was founded by Nandlal Mulji Bhuta

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.66%
1 Week
-1.11%
1 Month
-1.41%
3 Month
+11.76%
6 Month
+22.10%
1 Year
+5.85%
2 Year
+59.50%
5 Year
+10.34%
10 Year
+776.11%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 30.05 31.77 29.28 28.55 29.75 28.54 18.89 18.49 20.66
Return on Capital Employed (%) 40.94 42.35 40.17 39.26 41.99 36.90 25.73 23.83 26.89
Return on Assets (%) 16.15 18.40 18.13 20.10 22.36 21.99 14.37 14.68 16.95

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 27 33 40 54 61 77 80 98 117 125
Non Curr. Liab. 4 3 4 4 3 0 5 4 4 3
Curr. Liab. 13 24 14 18 13 25 20 18 21 17
Minority Int.
Equity & Liab. 44 61 58 76 78 103 104 120 143 146
Non Curr. Assets 14 12 13 13 12 13 15 40 67 69
Curr. Assets 30 49 45 64 66 90 90 80 76 77
Misc. Exp. not W/O
Total Assets 44 61 58 76 78 103 104 120 143 146

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 76 85 94 103 115 123 119 109 124 128
Other Income 2 2 3 3 3 3 4 4 5 5
Total Income 78 87 96 106 118 126 123 114 129 133
Total Expenditure -65 -70 -77 -84 -91 -98 -99 -89 -97 -101
PBIDT 13 17 19 23 27 28 24 24 32 32
Interest -1 0 0 0 0 0 -1 0 0 0
Depreciation -2 -3 -2 -2 -2 -1 -2 -2 -2 -2
Taxation -3 -5 -6 -7 -8 -7 -6 -5 -8 -7
Exceptional Items 0 0 0
PAT 8 10 11 14 17 20 15 17 22 22
Adjusted EPS 16 21 23 29 38 43 32 36 49 49

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 11 9 8 10 16 13 15 19 9
Cash Fr. Inv. -1 0 1 0 -10 1 -11 -3 -19 -1
Cash Fr. Finan. 0 -7 1 -5 1 -18 -2 -11 -1 -6
Net Change 3 5 11 2 1 -1 0 1 0 3
Cash & Cash Eqvt 11 17 28 30 2 1 1 3 2 5

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 45.73 45.73 45.73 45.73 45.73 45.73 45.73 45.73 45.97
Public 54.27 54.27 54.27 54.27 54.27 54.27 54.27 54.27 54.03
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 27 Jan 2023
Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Please find enclosed the details of the daily reporting of shares brought back by the Company on 27.01.2023.
Fri, 27 Jan 2023
Board Meeting Intimation for The Unaudited Financial Results For The Quarter And Nine Months Ended On 31St December 2022.
JENBURKT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2023 inter alia to consider and approve the unaudited financial results for the quarter and nine months ended on 31st December 2022.
Wed, 25 Jan 2023
Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Please find enclosed the details of the daily reporting of shares brought back by the Company on 25.01.2023.

Technical Scans View Details >>

Fri, 27 Jan 2023
High Delivery Percentage High Delivery Percentage
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Jenburkt Pharmaceuticals Ltd.

What is Jenburkt Pharma share price?

Can I buy Jenburkt Pharma shares now?

What is the Dividend Yield of Jenburkt Pharma?

What is the Market Cap of Jenburkt Pharma?

What are the key metrics to analyse Jenburkt Pharma?

What is the 52 Week High and Low of Jenburkt Pharma?

What is the trend of Jenburkt Pharma share price?